InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (44 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
44
T+90 hit rate
15%
T+90 mean return
-20.4%
Across 26 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Saxonov Serge, Chief Executive Officer. Director active across 1 company, notably 10x Genomics, Inc.. In total, 87 filings have been recorded. Split: 0 buy · 44 sells. Total volume traded: €3.9m. Activity tracked since 4 May 2021. The latest transaction was filed on 26 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations87 total
8,527 sharesClass A Common StockSEC:0001610717-26-000293:0
9,991 sharesClass A Common StockSEC:0001610717-26-000293:1
9,821 sharesClass A Common StockSEC:0001610717-26-000293:2
1,661 sharesClass A Common StockSEC:0001610717-26-000293:3
18,175 shares@ US$24.44150.018% mcap8.4% of flowClass A Common StockSEC:0001610717-26-000164:0
10,718 shares@ US$24.70920.011% mcap5.0% of flowClass A Common StockSEC:0001610717-26-000164:1
13,261 shares@ US$18.99834.8% of flowClass A Common StockSEC:0001610717-25-000398:0
900 shares0Class A Common StockSEC:0001610717-25-000341:0
9,348 shares@ US$13.7872.4% of flowClass A Common StockSEC:0001610717-25-000321:0
9,343 shares@ US$8.29931.5% of flowClass A Common StockSEC:0001610717-25-000144:0
171,428 shares0Class A Common StockSEC:0001610717-25-000075:0
50,000 shares@ US$1.201.3% of flowClass A Common StockSEC:0001610717-25-000049:1
7,942 shares@ US$10.62621.8% of flowClass A Common StockSEC:0001610717-25-000049:0
5,092 shares@ US$11.06561.2% of flowClass A Common StockSEC:0001610717-25-000036:0
12,000 shares@ US$1.200.3% of flowClass A Common StockSEC:0001610717-24-000554:0
1,850 shares0Class A Common StockSEC:0001610717-24-000530:0
1,350 shares0Class A Common StockSEC:0001610717-24-000524:0
6,749 shares@ US$22.52973.0% of flowClass A Common StockSEC:0001610717-24-000455:0
425 shares0Class A Common StockSEC:0001610717-24-000271:0
4,877 shares@ US$24.30362.4% of flowClass A Common StockSEC:0001610717-24-000258:0
88,854 shares0Class A Common StockSEC:0001610717-24-000186:0
1,086 shares0Class A Common StockSEC:0001610717-24-000163:0
4,660 shares@ US$43.99594.1% of flowClass A Common StockSEC:0001610717-24-000135:0
2,821 shares@ US$46.34432.6% of flowClass A Common StockSEC:0001610717-24-000092:0
3,300 shares@ US$48.57583.3% of flowClass A Common StockSEC:0001610717-24-000071:0
25 of 87 declarations
About Saxonov Serge
Serge Saxonov, Ph.D., co-founded 10x Genomics, Inc. and has served as its Chief Executive Officer and as a director since July 2012. Before co-founding the company, he was Vice President of Applications at QuantaLife from May 2010 to April 2012, and prior to that he was Founding Architect and Director of Research and Development at 23andMe from June 2006 to May 2010. He holds a Ph.D. in Biomedical Informatics from Stanford University and an A.B. in Applied Mathematics from Harvard College. Sources: https://www.10xgenomics.com/company/board/serge-saxonov
